PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

NICE recommends Biomarin’s Vimizim for patients with rare life-limiting metabolic disorder

Patients with a life-limiting skeletal condition welcome the availability of elosulfase alfa on the NHS The National Institute for Health and Care Excellence (NIC...
Continue Reading →
News

BridgeBio shares promising data from muscular dystrophy drug trial

The California-based biotech announced positive results from their latest limb-girdle muscular dystrophy type 2i (LGMD2i) program trials, linking their dru...
Continue Reading →
News

COVID-19 infections seeing spike across UK

In the coming months, an additional vaccine booster will be offered to those over 75, care home residents and to those over 12 who are most vulnerable COVID-19 ca...
Continue Reading →
News

State-of-the-art R&D facilities to be developed in Oxford city centre

The site will include creating space for student accommodation, offices, retail outlets and restaurants Oxford Science Enterprises has entered an agreement with L...
Continue Reading →
News

FDA approves first generic of Symbicort to treat asthma and COPD

The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of ...
Continue Reading →
News

Abivax reports promising rheumatoid arthritis results

Treatment demonstrated a good safety profile in the overall patient population during the 12-week induction phase Clinical-stage biotechnology company, Abivax, ha...
Continue Reading →
News

New antiviral medicines initiative launched for future pandemics

The Novo Nordisk Foundation, Open Philanthropy, and the Bill & Melinda Gates Foundation have announced an initial commitment of up to $90 million of coordinated ...
Continue Reading →
News

Gene team supports therapies for previously untreatable brain regions

Novartis and Voyager Therapeutics announce partnership to develop gene therapies for neurological disorders In a promising step for next-generation gene therapy f...
Continue Reading →
News

Cell door: EMA grants ATMP classification to CELTIC-19

Advanced Therapy Medicinal Product classification for Ixaka Ltd’s chemically encapsulated lentiviral vector The EMA has granted an Advanced Therapy Medicinal Prod...
Continue Reading →
News

Roche launches molecular system to increase diagnostic testing access

A fully-automated molecular system with a small footprint provides greater flexibility for laboratories without much space Roche Diagnostics has announced the lau...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026